Volume 13, Issue 11, Pages (November 2006)

Slides:



Advertisements
Similar presentations
RNA-Catalyzed RNA Ligation on an External RNA Template
Advertisements

Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Barry L Stoddard, Gregory K Farber  Structure 
Miglena Manandhar, John E. Cronan  Chemistry & Biology 
Volume 18, Issue 12, Pages (December 2011)
Volume 15, Issue 5, Pages (May 2008)
Mahmoud Ghanem, Andrew S. Murkin, Vern L. Schramm  Chemistry & Biology 
Volume 14, Issue 9, Pages (September 2007)
Kenneth Wu, Jordan Kovacev, Zhen-Qiang Pan  Molecular Cell 
Heme-Artemisinin Adducts Are Crucial Mediators of the Ability of Artemisinin to Inhibit Heme Polymerization  R Kannan, Dinkar Sahal, V.S Chauhan  Chemistry.
Peter Bernhardt, Elizabeth McCoy, Sarah E. O'Connor 
Volume 10, Issue 9, Pages (September 2003)
Volume 8, Issue 8, Pages (January 2001)
An FAD-Dependent Pyridine Nucleotide-Disulfide Oxidoreductase Is Involved in Disulfide Bond Formation in FK228 Anticancer Depsipeptide  Cheng Wang, Shane.
(a) (b) FhGALE M U I S W1 W2 E1 E2 E3 M - +
Highly Efficient Self-Replicating RNA Enzymes
Volume 19, Issue 2, Pages (February 2012)
Identification and Characterization of the Lysobactin Biosynthetic Gene Cluster Reveals Mechanistic Insights into an Unusual Termination Module Architecture 
Volume 14, Issue 1, Pages (January 2007)
Volume 23, Issue 10, Pages (October 2016)
Volume 17, Issue 1, Pages (January 2010)
Kento Koketsu, Hiroki Oguri, Kenji Watanabe, Hideaki Oikawa 
Volume 13, Issue 5, Pages (May 2006)
Volume 15, Issue 5, Pages (May 2008)
Carl J. Balibar, Sylvie Garneau-Tsodikova, Christopher T. Walsh 
Volume 18, Issue 11, Pages (November 2011)
Volume 19, Issue 5, Pages (May 2012)
Active site labeling of the gentamicin resistance enzyme AAC(6′)-APH(2″) by the lipid kinase inhibitor wortmannin  David D. Boehr, William S. Lane, Gerard.
Volume 74, Issue 5, Pages (May 1998)
Sherry S. Lamb, Tejal Patel, Kalinka P. Koteva, Gerard D. Wright 
Volume 17, Issue 1, Pages (January 2010)
RNA-Catalyzed Thioester Synthesis
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
Scott Gradia, Samir Acharya, Richard Fishel  Cell 
Volume 22, Issue 2, Pages (February 2015)
Volume 11, Issue 11, Pages (November 2004)
Volume 14, Issue 7, Pages (July 2007)
Conversion of L-Proline to Pyrrolyl-2-Carboxyl-S-PCP during Undecylprodigiosin and Pyoluteorin Biosynthesis  Michael G Thomas, Michael D Burkart, Christopher.
Volume 18, Issue 11, Pages (November 2011)
Volume 9, Issue 10, Pages (October 2002)
Volume 18, Issue 5, Pages (May 2011)
Volume 12, Issue 11, Pages (November 2005)
Volume 14, Issue 12, Pages (December 2007)
Tandem Enzymatic Oxygenations in Biosynthesis of Epoxyquinone Pharmacophore of Manumycin-type Metabolites  Zhe Rui, Moriah Sandy, Brian Jung, Wenjun Zhang 
In Vivo Resolution of Conflicting In Vitro Results: Synthesis of Biotin from Dethiobiotin Does Not Require Pyridoxal Phosphate  Ahmed M. Abdel-Hamid,
Volume 12, Issue 1, Pages (January 2005)
Volume 13, Issue 12, Pages (December 2006)
Inhibitor Mediated Protein Degradation
Michael J. Bowman, Simon Byrne, Jean Chmielewski  Chemistry & Biology 
Nickel2+-Mediated Assembly of an RNA-Amino Acid Complex
Volume 20, Issue 7, Pages (July 2013)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Transport of Biotin in Human Keratinocytes
Volume 21, Issue 9, Pages (September 2014)
Mahmoud Ghanem, Andrew S. Murkin, Vern L. Schramm  Chemistry & Biology 
A Universal Screening Assay for Glycosynthases: Directed Evolution of Glycosynthase XynB2(E335G) Suggests a General Path to Enhance Activity  Alon Ben-David,
Kiyohiko Kawai, Yasuko Osakada, Mamoru Fujitsuka, Tetsuro Majima 
Controlling Protein Activity with Ligand-Regulated RNA Aptamers
Volume 18, Issue 12, Pages (December 2011)
Volume 5, Issue 4, Pages (April 2000)
Ali Sadeghi-Khomami, Michael D. Lumsden, David L. Jakeman 
Volume 14, Issue 5, Pages (May 2007)
RNA-Catalyzed RNA Ligation on an External RNA Template
Volume 18, Issue 11, Pages (November 2011)
Features of Selective Kinase Inhibitors
A One-Pot Chemoenzymatic Synthesis for the Universal Precursor of Antidiabetes and Antiviral Bis-Indolylquinones  Patrick Schneider, Monika Weber, Karen.
Volume 13, Issue 3, Pages (February 2004)
H3K4me3 Stimulates the V(D)J RAG Complex for Both Nicking and Hairpinning in trans in Addition to Tethering in cis: Implications for Translocations  Noriko.
Characterization of a Specificity Factor for an AAA+ ATPase
Volume 15, Issue 5, Pages (May 2008)
Presentation transcript:

Volume 13, Issue 11, Pages 1161-1169 (November 2006) Biosynthesis of Lovastatin Analogs with a Broadly Specific Acyltransferase  Xinkai Xie, Kenji Watanabe, Wladyslaw A. Wojcicki, Clay C.C. Wang, Yi Tang  Chemistry & Biology  Volume 13, Issue 11, Pages 1161-1169 (November 2006) DOI: 10.1016/j.chembiol.2006.09.008 Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 1 Lovastatin (1), Simvastatin (2), Monacolin J (3), Pravastatin (5), Huvastatin (6), and 6-Hydroxyl-6-Desmethylmonacolin J (7) Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 2 Proposed Acyl Transfer Reaction in A. terreus The reaction likely follows a ping-pong bi-bi mechanism. LovD first captures the α-methylbutyryl acyl group synthesized by the megasynthase LovF, followed by the transacylation of the C8-hydroxyl moiety of monacolin J to yield the natural product lovastatin. Ser76 is the putative active site nucleophile. Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 3 Expression and Purification of LovD from E. coli BL21(DE3)/pAW31 Lane 1, Flow through of whole cell lysate soluble protein over the Ni-NTA column; lane 2, 10 mM imidazole wash; lane 3, 20 mM imidazole wash; lane 4, 50 mM imidazole wash; lane 5, 250 mM imidazole elution 1; lane 6, 250 mM imidazole elution 2; and lane M, broad range molecular weight marker. The size of the N-6× His-LovD is 48 kDa. Only the protein in lane 5 was concentrated, buffer exchanged, and used in assays described here. Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 4 Verification of LovD Activity (A) HPLC (238 nm) trace showing formation of 4 by LovD-mediated acyl transfer. Gradient: 60% B–95% B, 5 min; 95% B, 15 min; (a) LovD + 3 + butyryl-CoA time course (0, 1, 3, 6, and 10 hr); (b) LovD S76A + 3 + butyryl-CoA, 10 hr; (c) LovD + butyryl-SNAC, 10 hr; (d) LovD + butyryl-SMTG, 10 hr. Assay conditions: 1 mM 3, 4 mM butyryl-CoA, 10 μM LovD, 50 mM HEPES, pH 7.9, 25°C. (B) Conversion as a function of time for butyryl-CoA (open diamonds), butyryl-SNAC (closed diamonds), and butyryl-SMTG (closed squares). The apparent kcat values reported throughout the text are initial turnover rates in the linear range. (C) LovD catalyzed hydrolysis of 1 to 3. The reaction progress is monitored by HPLC. kcat: 0.21 ± 0.01 min−1; Km: 0.56 ± 0.05 mM. Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 5 Kinetic Properties of LovD using Butyryl-CoA as an Acyl Substrate (A) Kinetic analysis of LovD catalyzed acylation of 3 in the presence of butyryl-CoA. Initial turnover rates (V/Eo) as a function of butyryl-CoA concentration with different concentrations of 3. The lines are fitted with nonlinear least squares regression to Michaelis-Menten kinetics. The concentrations of 3 used in these assays were 0.05 mM (closed diamonds), 0.2 mM (open squares), 0.5 mM (closed triangles), and 1 mM (closed circles). (B) Lineweaver-Burk plot of data shown in Figure 5A reveals that 3 is a competitive inhibitor of the acylation reaction; the kcat is estimated to be ∼0.53 min−1 from the intercept of the lines. Inset: the apparent Km values of butyryl-CoA increase as the concentration of 3 is increased. The actual Km of butyryl-CoA and KI of 3 are determined to be 1.59 ± 0.15 mM and 330 ± 36 μM. Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 6 Activity of LovD towards Acyl-SNAC substrates (A) HPLC (238 nm) trace showing formation of 1 and 2 by LovD-mediated acyl transfer. The gradient is the same as that described in Figure 4. (a) authentic standards of 1 and 2; (b) 3 + α-S-methylbutyryl-SNAC; (c) 3 + α-dimethylbutyryl-SNAC. Assay conditions: 1 mM 3, 10 mM acyl-SNAC, 100 μM LovD, 50 mM HEPES, pH 7.9, 25°C, 6 hr. (B) HPLC (238 nm) traces showing formation of 5 and 6 by LovD-mediated acylation of the tetra-ol 7. Gradient: 5% B–95% B, 5 min; 95% B, 15 min; (a) authentic standards of 5 and 7; (b) 7 + α-S-methylbutyryl-SNAC; (c) 7 + α-dimethylbutyryl-SNAC. Assay conditions: 1 mM 3, 10 mM acyl-SNAC, 100 μM LovD, 50 mM HEPES, pH 7.9, 25°C, 6 hr. Chemistry & Biology 2006 13, 1161-1169DOI: (10.1016/j.chembiol.2006.09.008) Copyright © 2006 Elsevier Ltd Terms and Conditions